Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial

BACKGROUND: The identification of biomarkers that predict optimal and individual choices of treatment for patients with rheumatoid arthritis gains increasing attention. The purpose of this study was to investigate if the proto-oncogene survivin might aid in treatment decisions in early rheumatoid ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Levitsky, Adrian, Erlandsson, Malin C., van Vollenhoven, Ronald F., Bokarewa, Maria I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589197/
https://www.ncbi.nlm.nih.gov/pubmed/26420684
http://dx.doi.org/10.1186/s12916-015-0485-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589197/
https://www.ncbi.nlm.nih.gov/pubmed/26420684
http://dx.doi.org/10.1186/s12916-015-0485-2

Ejemplares similares